Fifth Third Bancorp
CSCI

Fifth Third Bancorp’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Fifth Third Bancorp’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2
Closed -$22K – 2496
2014
Q3 		$22K Hold
2
– – ﹤0.01% 1739
2014
Q2 		$19K Hold
2
– – ﹤0.01% 1832
2014
Q1 		$19K Hold
2
– – ﹤0.01% 1815
2013
Q4 		$23K Hold
2
– – ﹤0.01% 1620
2013
Q3 		$25K Hold
2
– – ﹤0.01% 1587
2013
Q2 		$31K Buy
+2
New +$37.9K ﹤0.01% 1456

Other funds holding CSCI

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fifth Third Bancorp's CSCI Position: Q4 2014 in Review

Fifth Third Bancorp sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2014, closing a stake of 2 shares — an estimated $22K sold.

Fifth Third Bancorp first reported a position in CSCI in Q2 2013 and held it in 6 quarters. The position peaked at $31K in Q2 2013. 18 funds tracked by Wall St. Rank hold CSCI as of Q4 2014.

  • Fifth Third Bancorp reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Fifth Third Bancorp sold 2 COSCIENS Biopharma Inc. Common Stock shares in Q4 2014, an estimated $22K.
  • Fifth Third Bancorp first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • Fifth Third Bancorp's COSCIENS Biopharma Inc. Common Stock position peaked at $31K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2014.

Based on Fifth Third Bancorp's 13F filing for Q4 2014, filed 13 Feb 2015.